Key result
Gradual enoxaparin reintroduction yields no thrombosis or rebleeding after aortic dissection in a mechanical valve patient.
Why the study?
Managing anticoagulation poses a major dilemma between bleeding and thromboembolism risks in patients with mechanical heart valves who develop acute aortic dissection or catastrophic bleeding.
Case Report (n=1)
No
Gradual reintroduction of enoxaparin after withholding anticoagulation for one week may be a feasible strategy for managing patients with mechanical heart valves who experience acute life-threatening bleeding such as aortic dissection.
May support cautious reinitiation strategies in select mechanical valve cases; leaves open need for prospective validation.
Acute aortic dissections are considered surgical emergencies because they are catastrophic bleeding events. The risk of bleeding is further increased if the patient requires anticoagulation for other comorbidities, such as a mechanical heart valve. This case study describes a 73-year-old gentleman who presented with massive hemoptysis due to an acute aortic dissection complicated by pulmonary hemorrhage in the context of previous aortic dissection with multiple repair surgeries and residual chronic aortic dissection. He was also on warfarin for a mechanical aortic valve complicated by supratherapeutic international normalized ratio. His acute aortic dissection was treated conservatively without surgery, and he survived. Concerning the risk of thromboembolism from the mechanical aortic valve, anticoagulation was reintroduced one week after his initial bleeding. We changed warfarin to enoxaparin, which was started at a small dose, 40 mg subcutaneously once a day, then gradually increased to the full therapeutic dose, 90 mg (1 mg/kg) twice daily over a week. He was not fully anticoagulated for two weeks. Fortunately, he did not develop any thrombosis. Hemoglobin and Factor Xa levels were closely monitored. He tolerated the enoxaparin without further bleeding. This type of case is rare and has not been previously reported, considering the patient survived acute aortic dissection with conservative management, did not develop any thrombosis from the mechanical aortic valve when anticoagulation was withheld, and did not experience rebleeding when anticoagulation was restarted. Further research and guidelines are needed to assist clinicians in managing anticoagulation when facing the dilemmas of the risk of bleeding and the risk of thromboembolism. This is particularly important in complex scenarios, such as for patients with mechanical heart valves who subsequently develop contraindications such as aortic dissection or other life-threatening bleeding events.
No takes yet. Share an insight, caveat, or question.
Xia et al. (2024) conducted a case report in Acute aortic dissection with pulmonary hemorrhage and mechanical aortic valve (n=1). Enoxaparin (withholding and gradual reintroduction) was evaluated. Gradual reintroduction of enoxaparin after withholding anticoagulation for an acute aortic dissection in a patient with a mechanical aortic valve resulted in no thrombosis or rebleeding.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: